The global legionella testing market in terms of revenue was estimated to be worth $296.0 million in 2022 and is poised to reach $439.0 million by 2027, growing at a CAGR of 8.2% from 2022 to 2027

The Legionella testing market is expected to grow significantly over the forecast period due to the increasing prevalence of Legionnaires’ disease, a respiratory infection caused by the bacteria Legionella pneumophila, and the rising demand for water safety testing in both commercial and residential spaces.

Legionella is a type of bacteria that is found in both natural and man-made water systems, and it can cause serious infections in humans if it is not properly monitored and managed.

Download Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173145333

The growth of the Legionella testing market is driven by the increasing awareness of Legionnaires’ disease, the growing demand for water safety testing, and the availability of new testing methods. The increasing prevalence of the disease has raised awareness about the importance of testing for Legionella, leading to the growing demand for Legionella testing services.

Driver: Rapid increase of pneumonia and Legionella-related illnesses

According to the European Centre for Disease Prevention and Control (ECDC) (May 2022), Legionnaires' disease remains an uncommon and mainly sporadic respiratory infection with an overall notification rate of 1.9 cases per 100,000 population for the EU/EEA in 2020. France, Germany, Italy, and Spain accounted for 72% of all notified cases. In addition, according to the US CDC (March 2022), the age-standardized average incidence was 0.48 cases per 100,000 population during 1992–2002, compared with 2.71/100,000 in 2018.

Opportunity: Legal requirements for water testing

The Environment Protection Agency (EPA) (October 2021) sets legal limits on over 90 contaminants in the US for drinking water. The legal limit for a contaminant reflects the level that protects human health and that water systems can achieve using the best available technology. EPA rules also set water-testing schedules and methods that water systems must follow. 

Restraint: lack of reimbursement policies

The major factor restraining the growth of the legionella testing market is inadequate reimbursements. According to MedPAC (Medicare Payment Advisory Commission), medical testing has seen a 40% decline in reimbursement over the last 40 years.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173145333

Key Market Players

The major players operating in this legionella testing market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMérieux S.A. (France), Becton, Dickinson, and Company (US), Alere, Inc. (US), Eurofins Scientific (Luxembourg), Roche Diagnostics (Switzerland), Pall Corporation (Danaher) (US), Quidel Corporation (US), Eiken Chemical Co., Ltd. (Japan), Hologic, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Environmental Safety Technologies, Inc. (US), Hydrosense (Scotland), Accepta Ltd. (UK), LuminUltra Technologies Ltd. (Canada), Pro-Lab Diagnostics, Inc. (Canada), BioAlert Solutions (Canada), Pacific Water Technology (Australia), Aquacert Ltd. (UK), DTK Water (UK), Sens Solutions (Spain), Genomadix, Inc. (US), and Phigenics, LLC (US).

Key Topics Covered in Legionella Testing Market:

Chapter 1. Market Synopsis

Chapter 2. Executive Summary

Chapter 3. Indicative Metrics

Chapter 4. Legionella Testing Market Segmentation & Impact Analysis

Chapter 5. Legionella Testing Market By Product Insights & Trends

Chapter 6. Legionella Testing Market By Test Type Insights & Trends

Chapter 7. Legionella Testing Market By End-use Insights & Trends

Chapter 8. Legionella Testing Market Regional Outlook

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173145333

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com